Medical Properties Trust, Inc. (NYSE:MPW) Stock Position Raised by Wolverine Asset Management LLC

→ Could Your Accounts Be Frozen? (From Allegiance Gold) (Ad)

Wolverine Asset Management LLC raised its position in Medical Properties Trust, Inc. (NYSE:MPW - Free Report) by 86.5% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 363,815 shares of the real estate investment trust's stock after buying an additional 168,703 shares during the period. Wolverine Asset Management LLC owned about 0.06% of Medical Properties Trust worth $1,786,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of MPW. Deutsche Bank AG grew its position in shares of Medical Properties Trust by 880.2% in the third quarter. Deutsche Bank AG now owns 3,951,543 shares of the real estate investment trust's stock valued at $21,536,000 after purchasing an additional 3,548,423 shares during the period. Charles Schwab Investment Management Inc. grew its position in shares of Medical Properties Trust by 30.1% in the third quarter. Charles Schwab Investment Management Inc. now owns 8,610,221 shares of the real estate investment trust's stock valued at $46,926,000 after purchasing an additional 1,989,853 shares during the period. Lasalle Investment Management Securities LLC grew its position in shares of Medical Properties Trust by 49.6% in the third quarter. Lasalle Investment Management Securities LLC now owns 5,065,844 shares of the real estate investment trust's stock valued at $27,609,000 after purchasing an additional 1,680,200 shares during the period. AQR Capital Management LLC grew its position in shares of Medical Properties Trust by 125.3% in the third quarter. AQR Capital Management LLC now owns 2,261,451 shares of the real estate investment trust's stock valued at $12,325,000 after purchasing an additional 1,257,921 shares during the period. Finally, Connor Clark & Lunn Investment Management Ltd. grew its position in shares of Medical Properties Trust by 115.6% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,623,611 shares of the real estate investment trust's stock valued at $8,849,000 after purchasing an additional 870,606 shares during the period. Institutional investors and hedge funds own 71.79% of the company's stock.


Medical Properties Trust Stock Performance

MPW remained flat at $4.57 during trading hours on Thursday. 8,250,403 shares of the company traded hands, compared to its average volume of 22,282,674. Medical Properties Trust, Inc. has a 1 year low of $2.92 and a 1 year high of $10.74. The stock's 50-day moving average price is $4.25 and its 200 day moving average price is $4.35. The stock has a market cap of $2.73 billion, a price-to-earnings ratio of -4.86, a P/E/G ratio of 1.40 and a beta of 1.20. The company has a debt-to-equity ratio of 1.32, a quick ratio of 2.26 and a current ratio of 2.26.

Medical Properties Trust Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Investors of record on Monday, April 22nd will be paid a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a yield of 13.14%. The ex-dividend date of this dividend is Friday, April 19th. Medical Properties Trust's payout ratio is currently -63.83%.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on MPW. BNP Paribas upgraded shares of Medical Properties Trust from a "neutral" rating to an "outperform" rating and set a $6.00 price target on the stock in a research report on Friday, March 1st. Deutsche Bank Aktiengesellschaft upgraded shares of Medical Properties Trust from a "sell" rating to a "hold" rating and boosted their price target for the stock from $2.00 to $5.00 in a research report on Wednesday, April 17th. Colliers Securities lowered shares of Medical Properties Trust from a "buy" rating to a "neutral" rating and lowered their price target for the stock from $10.00 to $4.25 in a research report on Wednesday, April 10th. KeyCorp restated a "sector weight" rating on shares of Medical Properties Trust in a research report on Friday, January 5th. Finally, Royal Bank of Canada lowered their price target on shares of Medical Properties Trust from $8.00 to $5.00 and set an "outperform" rating on the stock in a research report on Tuesday, February 20th. Five research analysts have rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $5.75.

View Our Latest Analysis on Medical Properties Trust

Medical Properties Trust Profile

(Free Report)

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.

Further Reading

Institutional Ownership by Quarter for Medical Properties Trust (NYSE:MPW)

Should you invest $1,000 in Medical Properties Trust right now?

Before you consider Medical Properties Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medical Properties Trust wasn't on the list.

While Medical Properties Trust currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Featured Articles and Offers

Search Headlines: